Results 101 to 110 of about 242,337 (233)

Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis. [PDF]

open access: yesInt Ophthalmol, 2023
Dogan CU   +5 more
europepmc   +1 more source

The Oral‐Hepatic Axis: Epidemiological and Mechanistic Links Between Periodontal and Liver Diseases

open access: yesJournal of Periodontal Research, EarlyView.
This review summarizes current epidemiological, clinical and mechanistic evidence linking periodontitis and chronic liver diseases, highlighting the oral‐gut‐liver axis, shared immunometabolic and nutritional pathways and opportunities for integrated preventive and therapeutic strategies.
Sinem Esra Sahingur   +3 more
wiley   +1 more source

Occurrence of infections in dogs receiving ciclosporin in a single‐centre UK referral population

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives The study aimed (a) to describe the occurrence and nature of new infections in dogs receiving oral ciclosporin and (b) to identify any risk factors associated with the development of a new infection whilst receiving ciclosporin. Materials and Methods In this retrospective cohort study, medical records of dogs presented to a private UK ...
S. Dormon   +5 more
wiley   +1 more source

AQP1 Corrects Acinar Cells’ Secretion Deficits in Sjögren's Disease

open access: yesOral Diseases, EarlyView.
ABSTRACT Introduction Sjögren's disease (SjD) is a systemic autoimmune disease characterized by dry mouth, dry eyes, and profound fatigue. Preclinical studies suggest that AQP1 gene expression in salivary glands corrects salivary hypofunction in preclinical and clinical studies of radiation‐induced xerostomia and improves salivary and lacrimal function
Paola Perez   +12 more
wiley   +1 more source

Risks of cyclosporine therapy in paediatric age [PDF]

open access: yes, 2010
INTRODUCTION Cyclosporine has been found to be effective and safe in many inflammatory skin disorders such as psoriasis and atopic dermatitis (AD), in adults and in children. Its use in paediatrics is still under scope.
Brito, Maria João   +2 more
core  

Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action

open access: yesInternational Journal of Nanomedicine, 2017
Siti Hajar Musa,1 Mahiran Basri,1 Hamid Reza Fard Masoumi,1 Norashikin Shamsudin,2 Norazlinaliza Salim1 1Department of Chemistry, Faculty of Science, 2Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang ...
Musa SH   +4 more
doaj  

Growth Assessment in Children Under 12 Years With Moderate‐to‐Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background/Objective The multifactorial disease burden of moderate‐to‐severe atopic dermatitis (AD) may affect children's growth. We report height, weight, and body mass index (BMI) of children under 12 years old with moderate‐to‐severe AD in comparison to the general population.
Amy S. Paller   +11 more
wiley   +1 more source

Conjunctival T Cell Profile in Allogeneic Hematopoietic Stem Cell Transplant Patients after Instilling Topical Cyclosporine-A 0.1% Cationic Emulsion. [PDF]

open access: yesOphthalmol Ther, 2023
Tong L   +10 more
europepmc   +1 more source

Pediatric Lichen Planus Pemphigoides in a Child With Sickle Cell Disease: Cyclosporine Induction and Dupilumab Maintenance

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Lichen planus pemphigoides (LPP) is a rare autoimmune subepidermal blistering disorder that combines lichenoid lesions of lichen planus with immunopathologic features of pemphigoid disease. We report an 8‐year‐old boy with homozygous sickle cell disease and severe atopic dermatitis who developed diffuse pruritic violaceous papules followed by ...
Yumeng T. Engelking   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy